CERENIS THERAPEUTICS S A has a total of 21 patent applications. Its first patent ever was published in 2006. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are OHLENSCHLAEGER GERHARD, HOLMAN ANDREW J and NUTRITION SCIENCE PARTNERS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | Republic of Korea | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | United States | 2 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Wetterau John R | 10 |
#2 | Scott Robert A | 9 |
#3 | Dasseux Jean-Louis | 8 |
#4 | Oniciu Daniela Carmen | 8 |
#5 | Keyserling Constance H | 6 |
#6 | Zhu Lingyu | 5 |
#7 | Dasseux Jean-Louis H | 4 |
#8 | Autant Pierre | 4 |
#9 | Castan Catherine | 4 |
#10 | Guillard Herve | 4 |
Publication | Filing date | Title |
---|---|---|
KR20120004412A | Apolipoprotein a-i mimics | |
CN102083466A | Niacin and NSAID combination therapy | |
WO2008154023A1 | Novel uses of ppar delta agonists | |
WO2007023476A2 | Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria |